A detailed history of West Bancorporation Inc transactions in Pfizer Inc stock. As of the latest transaction made, West Bancorporation Inc holds 22,463 shares of PFE stock, worth $592,124. This represents 0.45% of its overall portfolio holdings.

Number of Shares
22,463
Previous 22,463 -0.0%
Holding current value
$592,124
Previous $628,000 3.5%
% of portfolio
0.45%
Previous 0.48%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 26, 2024

SELL
$25.26 - $29.6 $57,870 - $67,813
-2,291 Reduced 9.26%
22,463 $628,000
Q1 2024

Apr 30, 2024

SELL
$25.89 - $29.73 $43,365 - $49,797
-1,675 Reduced 6.34%
24,754 $686,000
Q4 2023

Jan 26, 2024

SELL
$26.13 - $33.94 $12,228 - $15,883
-468 Reduced 1.74%
26,429 $760,000
Q3 2023

Oct 27, 2023

SELL
$32.09 - $37.51 $9,177 - $10,727
-286 Reduced 1.05%
26,897 $892,000
Q2 2023

Jul 31, 2023

BUY
$36.12 - $41.79 $61,006 - $70,583
1,689 Added 6.63%
27,183 $997,000
Q1 2023

Apr 14, 2023

SELL
$39.39 - $51.28 $47,268 - $61,536
-1,200 Reduced 4.5%
25,494 $1.04 Million
Q4 2022

Jan 30, 2023

SELL
$41.75 - $54.5 $177,103 - $231,189
-4,242 Reduced 13.71%
26,694 $1.37 Million
Q3 2022

Oct 14, 2022

SELL
$43.76 - $53.42 $41,484 - $50,642
-948 Reduced 2.97%
30,936 $1.35 Million
Q2 2022

Jul 15, 2022

BUY
$46.53 - $55.17 $144,103 - $170,861
3,097 Added 10.76%
31,884 $1.67 Million
Q1 2022

Apr 29, 2022

BUY
$45.75 - $56.69 $573,750 - $710,949
12,541 Added 77.19%
28,787 $1.49 Million
Q4 2021

Feb 08, 2022

SELL
$41.32 - $61.25 $162,718 - $241,202
-3,938 Reduced 19.51%
16,246 $959,000
Q4 2019

Feb 10, 2020

BUY
$32.92 - $37.36 $664,457 - $754,074
20,184 New
20,184 $791,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $148B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track West Bancorporation Inc Portfolio

Follow West Bancorporation Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of West Bancorporation Inc, based on Form 13F filings with the SEC.

News

Stay updated on West Bancorporation Inc with notifications on news.